NEPHRON PHARMACEUTICALS CORP has a total of 21 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, machines and packaging and shipping are AQUESTIVE THERAPEUTICS INC, CIVITAS THERAPEUTICS INC and MONOSOL RX LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Packaging and shipping | |
#4 | Digital networks | |
#5 | Computer technology | |
#6 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Daugherty Ashley | 11 |
#2 | Primelles-Perez Eric | 8 |
#3 | Webb Travis John | 4 |
#4 | Hoover Jessica R | 3 |
#5 | Sims Jessica R | 1 |
#6 | Neil Jack | 1 |
#7 | Cehajic Nermin | 1 |
#8 | Jibaja Hank | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020197990A1 | Blockchain systems and methods for remote monitoring | |
US2019290633A1 | Tiotropium Inhalation Solution for Nebulization | |
US2019231769A1 | Tiotropium Inhalation Solution for Nebulization | |
AU2018318123A1 | Aqueous nebulization composition | |
CA2934961A1 | Budesonide cyclodextrin formulation | |
CA2929074A1 | Formulation of olopatadine | |
WO2013169289A1 | Container for liquid |